EUVIMEDEUVIMED entdecken
Open Access

Human placenta extract declines fat deposition in an in vitro novel 3D MASLD model

Parisa Taheri, Fatemeh Majidi, Kosar Nouri, Masoumeh Nouri, Morteza Zarrabi, Elham Rismani, Abbas Piryaei, Massoud Vosough iD

In vitro models · 28.07.2026 · 5 (4) · 689-705

DOI: 10.1007/s44164-026-00142-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift In vitro models, online erschienen am 28.07.2026. Verfasst von Parisa Taheri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Bahar Tashkhis Teb Co., Royan Institute of Iran, Royan Bon Yakhte Co..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common chronic liver disease, with an increasing incidence globally. Characterized by excessive lipid deposition, MASLD triggers chronic inflammation that can progress to metabolic dysfunction-associated steatohepatitis (MASH). Despite its growing burden, no approved treatment protocol exists, highlighting the need for novel therapeutic modalities. Due to lack of appropriate experimental models, research and development of innovative medications remains challenging. In this study, multicellular liver microtissues were generated by encapsulating human hepatoma (Huh-7), hepatic stellate (LX-2) and monocyte (THP-1) cell lines and umbilical vein endothelial (HUVEC) cells in a liver extracellular-derived hydrogel, mimicking the native hepatic microenvironment. MASLD pathogenesis was induced by exposing microtissues to defined concentrations of Oleic and Palmitic acids for 3 days. We evaluated the therapeutic potential of human placenta extract (hPE) on this biomimetic model. On day 4, post-MASLD-model formation, microtissues received 5 mg/ml hPE for 48 h. Assessments on day 6 showed significant improved cell viability, reduced lipid droplets, and restored hepatic synthetic functions, evidenced by enhanced albumin, alpha-fetoprotein, and urea levels. Additionally, hPE treatment declines lipid uptake and synthesis related genes (CD36 and SREBP) while upregulating fatty acid oxidation related gene (CPT1), decreased pro-inflammatory cytokines (IL-6 and TNF-α), and increased cytochrome P450 3A4 (CYP3A4) expression. Overall, hPE could alleviate MASLD complications in this bioengineered liver microtissue model and may be proposed as a potential candidate for further preclinical/clinical studies in MASLD. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s44164-026-00142-w.

Schlagwörter

Stichwörter der Autor:innen

Free fatty acidsHuman placental extractLiver microtissuesMetabolic dysfunction-associated steatotic liver disease

Autor:innen und Institutionen

  • Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
  • Department of Developmental Biology, University of Science and Culture, ACECR, Tehran, Iran.
  • Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
  • R & D Department, Royan Stem Cell Technology Co, Tehran, 1665666311 Iran.
  • Molecular Medicine Department, Biotechnology Research Center (BRC), Pasteur Institute of Iran, Tehran, Iran.
  • Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Massoud Vosough

Förderung

  • Bahar Tashkhis Teb Co.
  • Royan Institute of Iran
  • Royan Bon Yakhte Co.

Zitieren

APA

Taheri, P., Majidi, F., Nouri, K., Nouri, M., Zarrabi, M., Rismani, E., Piryaei, A., & Vosough, M. (2026). Human placenta extract declines fat deposition in an in vitro novel 3D MASLD model. In vitro models, 5(4), 689-705. https://doi.org/10.1007/s44164-026-00142-w

Vancouver

Taheri P, Majidi F, Nouri K, Nouri M, Zarrabi M, Rismani E, et al. Human placenta extract declines fat deposition in an in vitro novel 3D MASLD model. In vitro models. 2026;5(4):689-705. doi:10.1007/s44164-026-00142-w

BibTeX
@article{Taheri2026,
  author = {Taheri, Parisa and Majidi, Fatemeh and Nouri, Kosar and Nouri, Masoumeh and Zarrabi, Morteza and Rismani, Elham and Piryaei, Abbas and Vosough, Massoud},
  title = {Human placenta extract declines fat deposition in an in vitro novel 3D MASLD model},
  journal = {In vitro models},
  year = {2026},
  volume = {5},
  number = {4},
  pages = {689--705},
  doi = {10.1007/s44164-026-00142-w}
}
Kostenlos starten →